3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Tobacco Use Disorder
1
Thyroid Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mouth Neoplasms
1
Lichen Planus
1
Leukokeratosis, Hereditary Mucosal
1
Leukemia, Myeloid, Acute
1
Fanconi Anemia
1
Erythroplasia
1
COVID-19
1
Interventions
Cyclophosphamide
10
fludarabine phosphate
9
Peripheral Blood Stem Cell Transplantation
8
Cyclosporine
8
Mycophenolic Acid
6
Busulfan
6
Filgrastim
5
Antilymphocyte Serum
5
Radiotherapy
4
Psychiatric Rehabilitation
4
Methotrexate
4
fludarabine
3
Whole-Body Irradiation
3
Tacrolimus
3
Melphalan
3
Flow Cytometry
3
Cord Blood Stem Cell Transplantation
3
Aprepitant
3
thymoglobulin
2
Therapeutics
2
Ondansetron
2
Methylprednisolone
2
Dexamethasone
2
Calcium Dobesilate
2
Analgesia
2
sargramostim
1
merphos
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Voriconazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Primary Myelofibrosis
×
Molecular Diagnostic Techniques
×
Clear all
NCT02435550
2019-12-20
iCare for Cancer Patients
University of Florida
Phase NA
Terminated
136 enrolled